Tingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, . . . Liang Ouyang. (2022). Author correction to "Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372]. Elsevier.
Chicago Style (17th ed.) CitationTingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen, and Liang Ouyang. Author Correction to "Development of Small-molecule Tropomyosin Receptor Kinase (TRK) Inhibitors for NTRK Fusion Cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372]. Elsevier, 2022.
MLA (9th ed.) CitationTingting Jiang, et al. Author Correction to "Development of Small-molecule Tropomyosin Receptor Kinase (TRK) Inhibitors for NTRK Fusion Cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372]. Elsevier, 2022.